Evidence map›Paper›PMID 19208356›Full record

ArticleGastroenterology2009

Notch signaling as gatekeeper of rat acinar-to-beta-cell conversion in vitro.

Luc Baeyens, Stefan Bonné, Tomas Bos, Ilse Rooman, Cindy Peleman, Tony Lahoutte, Michael German, Harry Heimberg, Luc Bouwens

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. β-Cell Regeneration Is Driven by Pancreatic Plasticity.Advances in anatomy, embryology, and cell biology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Notch Signaling in Pancreatic Development.International journal of molecular sciences · 2015
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Luc BaeyensDiabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.
Stefan Bonné
Tomas Bos
Ilse Rooman
Cindy Peleman
Tony Lahoutte
Michael German
Harry Heimberg
Luc Bouwens
Vrije Universiteit Brussel · BEUniversity of California, San Francisco · US

Funding

DIFFERENTIATION IN THE ENDOCRINE AND EXOCRINE PANCREASR01DK021344 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GERMAN, MICHAEL S · 1986 to 2014
$3.4M
NIDDK NIH HHS R01 DK021344
6 · The paper itself

Abstract

BACKGROUND &

aimsExocrine acinar cells in the pancreas are highly differentiated cells that retain a remarkable degree of plasticity. After isolation and an initial phase of dedifferentiation in vitro, rodent acinar cells can convert to endocrine beta-cells when cultured in the presence of appropriate factors. The mechanisms regulating this phenotypic conversion are largely unknown.

methodsUsing rat acinar cell cultures, we studied the role of Notch signaling in a model of acinar-to-beta-cell conversion.

resultsWe report a novel lectin-based cell labeling method to demonstrate the acinar origin of newly formed insulin-expressing beta-cells. This method allows for specific tracing of the acinar cells. We demonstrate that growth factor-induced conversion of adult acinar cells to beta-cells is negatively regulated by Notch1 signaling. Activated Notch1 signaling prevents the reexpression of the proendocrine transcription factor Neurogenin-3, the key regulator of endocrine development in the embryonic pancreas. Interfering with Notch1 signaling allows modulating the acinar cell susceptibility to the differentiation-inducing factors. Its inhibition significantly improves beta-cell neoformation with approximately 30% of acinar cells that convert to beta-cells. The newly formed beta-cells mature when transplanted ectopically and are capable of restoring normal blood glycemia in diabetic recipients.

conclusionsWe report for the first time an efficient way to reprogram one third of the acinar cells to beta-cells by adult cell type conversion. This could find application in cell replacement therapy of type 1 diabetes, provided that it can be translated from rodent to human models.

Indexed as

Signal TransductionAnimalsCells, CulturedCell TransdifferentiationInsulin-Secreting CellsMaleMiceMice, NudePancreas, ExocrineRatsRats, WistarReceptor, Notch1RNA, MessengerReceptor, Notch1RNA, Messenger

Identifiers

PMID19208356
OpenAlexW1979928692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.